LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Dried Urine Spots Detect Cytomegalovirus in Newborns

By LabMedica International staff writers
Posted on 21 Jun 2012
Dried urine spots (DUS) can be used to provide a simple screening tool for congenital Cytomegalovirus (CMV) infection in newborn infants.

A standardized method for CMV quantification from DUS has been developed that uses molecular technology to detect and quantify the viral load in urinary samples.

Scientists at Johns Hopkins Medical Institutions (Baltimore, MD, USA) collected and tested archived urine samples from 27 congenitally infected and 15 uninfected neonates. DNA was extracted using an automated method from urine samples placed on filter paper discs. A quantitative CMV real-time polymerase chain reaction (rt-PCR) assay was performed on the extracted DNA, spiked urine samples, and suitable control samples.

Urine samples from congenitally infected newborns and negative controls either were diluted 1:10 or applied on filter paper at the same volume. The analytical sensitivity was determined of 100% of replicates at 7,500 CMV copies/mL. The actual detection limit was 22 DNA copies/disc. DNA copy number from DUS correlated well with copy number from 1:10 diluted urine, although there was a trend for lower levels from DUS. Amplification was performed on a 7500 Real-Time PCR System (Applied Biosystems; Foster City, CA, USA).

Concentrations of CMV DNA in the 27 positive samples ranged from 4.4 to 8.8 log10 copies/mL, with a mean of 6.5 log10 copies/mL. Three samples had CMV DNA levels that were greater than the highest concentration of the spikes urine tested for measurable range calculation. This screening method could be used to detect the presence of congenital CMV infection by inserting a filter paper in the newborn's diaper and therefore for this purpose, quantification may not be necessary.

The authors concluded that the assay may provide a simple and rapid tool for CMV detection and quantification from DUS in underdeveloped or developing countries in which diagnostic capabilities for CMV are lacking. Information on CMV prevalence from resource-constrained areas is currently limited due to lack of diagnostic infrastructure. The study was published on June 1, 2012, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Johns Hopkins Medical Institutions
Applied Biosystems

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Pipette
Accumax Smart Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more